文献速递产科母胎医学

分娩期产妇发热:病因、后果与临床管理

Maternal fever in labor: etiologies, consequences, and clinical management.
PubMed 文献 · Am J Obstet Gynecol · 2023-03-20

分娩期发热常见,约1.4%的足月临床绒毛膜羊膜炎产妇发展为严重脓毒症。炎症与高热可降低子宫收缩力,使剖宫产和产后出血风险增加2至3倍。一项双盲随机试验显示,高剂量缩宫素方案(6×6 mU/min)较低剂量方案(2×2 mU/min)显著降低分娩期发热率(10.4% vs 15.6%;风险比0.67;95%CI 0.48-0.92)。

要点

  • 足月临床绒毛膜羊膜炎产妇中约1.4%发展为严重脓毒症。
  • 产妇发热>39°C时新生儿脑病或需治疗性低温的比例高于38°C至39°C(1.1% vs 4.4%;P<.01)。
  • 分娩期发热不是以改善新生儿结局为目的中断产程行剖宫产的指征。

核心结论

  • 分娩期发热与炎症可降低子宫收缩力,使剖宫产和产后出血风险增加2至3倍。
  • 分娩期发热可能降低胎儿缺氧性脑损伤的阈值。
  • 应尽力降低分娩期发热风险;发热发生后应 prompt 启动抗生素治疗,对乙酰氨基酚可能无效。
  • 无证据表明减少胎儿暴露于分娩期发热的时间可预防已知不良新生儿结局,故分娩期发热不是以改善新生儿结局为目的行剖宫产的指征。
  • 临床医生应准备应对产后出血风险增加,分娩时备好宫缩剂。

研究设计与样本

  • 综述,总结分娩期发热的病因、后果与临床管理。
  • 引用一项双盲随机试验:纳入>36周妊娠初产妇,比较高剂量缩宫素方案(6×6 mU/min)与低剂量方案(2×2 mU/min)。
  • 引用一项大型队列研究:分娩期发热合并胎儿酸中毒尤其有害。

主要发现

  • 足月临床绒毛膜羊膜炎产妇中仅约1.4%发展为严重脓毒症。
  • 分娩期发热使剖宫产和产后出血风险增加2至3倍。
  • 产妇发热>39°C时新生儿脑病或需治疗性低温的比例为4.4%,高于38°C至39°C的1.1%(P<.01)。
  • 硬膜外镇痛暴露时间和未用药产妇的产程长度仍是分娩期发热的重要危险因素。
  • 高剂量缩宫素方案(6×6 mU/min)较低剂量方案(2×2 mU/min)降低分娩期发热率:10.4% vs 15.6%;风险比0.67;95%CI 0.48-0.92。

关键数值与推荐

  • 足月临床绒毛膜羊膜炎产妇中约1.4%发展为严重脓毒症。
  • 分娩期发热使剖宫产和产后出血风险增加2至3倍。
  • 产妇发热>39°C vs 38°C至39°C:新生儿脑病或需治疗性低温比例1.1% vs 4.4%(P<.01)。
  • 高剂量缩宫素(6×6 mU/min)vs 低剂量缩宫素(2×2 mU/min):分娩期发热率10.4% vs 15.6%;风险比0.67;95%CI 0.48-0.92。

临床怎么用

  • 应尽力降低分娩期发热风险,注意维持产程进展。
  • 发热发生时应及时启动抗生素治疗;对乙酰氨基酚可能无效。
  • 分娩期发热不是以改善新生儿结局为目的中断产程行剖宫产的指征。
  • 分娩时应备好宫缩剂以预防产后出血治疗延迟。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Intrapartum fever is common and presents diagnostic and treatment dilemmas for the clinician. True maternal sepsis is rare; only an estimated 1.4% of women with clinical chorioamnionitis at term develop severe sepsis. However, the combination of inflammation and hyperthermia adversely impacts uterine contractility and, in turn, increases the risk for cesarean delivery and postpartum hemorrhage by 2- to 3-fold. For the neonate, the rates of encephalopathy or the need for therapeutic hypothermia have been reported to be higher with a maternal fever >39°C when compared with a temperature of 38°C to 39°C (1.1 vs 4.4%; P<.01). In a large cohort study, the combination of intrapartum fever and fetal acidosis was particularly detrimental. This suggests that intrapartum fever may lower the threshold for fetal hypoxic brain injury. Because fetal hypoxia is often difficult to predict or prevent, every effort should be made to reduce the risk for intrapartum fever. The duration of exposure to epidural analgesia and the length of labor in unmedicated women remain significant risk factors for intrapartum fever. Therefore, paying careful attention to maintaining labor progress can potentially reduce the rates of intrapartum fever and the risk for cesarean delivery if fever does occur. A recent, double-blind randomized trial of nulliparas at >36 weeks' gestation demonstrated that a high-dose oxytocin regimen (6×6 mU/min) when compared with a low-dose oxytocin regimen (2×2 mU/min) led to clinically meaningful reductions in the rate of intrapartum fever (10.4% vs 15.6%; risk rate, 0.67; 95% confidence interval, 0.48-0.92). When fever does occur, antibiotic treatment should be initiated promptly; acetaminophen may not be effective in reducing the maternal temperature. There is no evidence that reducing the duration of fetal exposure to intrapartum fever prevents known adverse neonatal outcomes. Therefore, intrapartum fever is not an indication for cesarean delivery to interrupt labor with the purpose of improving neonatal outcome. Finally, clinicians should be ready for the increased risk for postpartum hemorrhage and have uterotonic agents on hand at delivery to prevent delays in treatment.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Goetzl L. Maternal fever in labor: etiologies, consequences, and clinical management. Am J Obstet Gynecol. 2023. PMID: 36997396. doi:10.1016/j.ajog.2022.11.002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。